Erik Harris Net Worth & Insider Trades

Erik Harris - EVP & Chief Commercial Officer, Ultragenyx Pharmaceutical Inc

As of September 6, 2023

What is Erik Harris's Net Worth?

The current estimated net worth of Ultragenyx Pharmaceutical Inc's EVP & Chief Commercial Officer, Erik Harris, is estimated to be about $2.59M . Erik Harris owns about 51,281 units of Ultragenyx Pharmaceutical Inc common stock. In the last 4 years at Ultragenyx Pharmaceutical Inc, Erik Harris has sold an estimated value of $1.66M worth.

What is Erik Harris's Past Insider Trading?

Erik Harris's largest sale order was 3,177 units , worth over $438.96K on March 3, 2021. In total, Erik Harris has made about 21 transactions over 4 years of their time at Ultragenyx Pharmaceutical Inc. Erik Harris usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 6,000 units , worth over $227.76K on September 6, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Erik Harris's' Mailing Address?

  • Mailing address is 60 Leveroni Court Novato CA 94949 CA

What are Ultragenyx Pharmaceutical Inc's Past Insider Trades?

Ultragenyx Pharmaceutical Inc's most recent insider trade came on October 24, 2023 by Richard Thomas Kassberg who sold 39,878 units worth $1.31M . In the last 9 years, insiders at Ultragenyx Pharmaceutical Inc have sold an estimated value of $125.36M and bought an estimated value of $18.58M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Alan Theodore Huizenga, SVP,  Shalini Sharp, EVP,  and Emil Kakkis, President & CEO .

Ultragenyx Pharmaceutical Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...